Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Neurology|September 5, 2014
Influence of BDNF Val66Met on the relationship between physical activity and brain volumeBelinda M Brown, Pierrick Bourgeat, Jeremiah J Peiffer, et al.Journal of Alzheimer'S Disease : JAD|April 14, 2009
Association of cardiovascular factors and Alzheimer's disease plasma amyloid-beta protein in subjective memory complainersKristyn A Bates, Hamid R Sohrabi, Mark Rodrigues, et al.Frontiers in Aging Neuroscience|April 14, 2022
The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older AdultsSteve Pedrini, Pratishtha Chatterjee, Akinori Nakamura, et al.Journal of Alzheimer'S Disease : JAD|December 9, 2025
Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's diseasePrita R Asih, Cameron W Morris, Hong Wang, et al.Journal of Alzheimer'S Disease : JAD|August 4, 2020
Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive PerformanceSteve Pedrini, Eugene Hone, Veer B Gupta, et al.Translational Psychiatry|October 31, 2018
Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of AgeingStephanie R Rainey-Smith, Yian Gu, Samantha L Gardener, et al.The International Journal of Neuroscience|April 27, 2016
Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging womenKristyn A Bates, Hamid R Sohrabi, Stephanie R Rainey-Smith, et al.Journal of Alzheimer'S Disease : JAD|September 6, 2011
Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle studyNoel G Faux, Kathryn A Ellis, Lorine Porter, et al.Ebiomedicine|October 22, 2024
Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platformAzadeh Feizpour, James David Doecke, Vincent Doré, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 23, 2019
Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's diseaseSaori Hata, Chiori Omori, Ayano Kimura, et al.Pageof 12